Enjoy complimentary customisation on priority with our Enterprise License!
The global clinical trial packaging market has the potential to grow by USD 667.92 million during 2020-2024, and the market’s growth momentum will accelerate throughout the forecast period because of the steady increase in year-over-year growth.
This report provides a detailed analysis of the market by end-user (pharmaceutical companies and other organizations) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Bilcare Ltd., Caligor Coghlan Pharma Services, Corden Pharma International GmbH, Mawdsley-Brooks & Co. Ltd., PCI Pharma Services, Piramal Enterprises Ltd., Sentry BioPharma Services, Sharp, The WestRock group, and Thermo Fisher Scientific Inc.
Browse TOC and LoE with selected illustrations and example pages of clinical trial packaging market
The clinical trial packaging market is moderately fragmented, and the degree of fragmentation will increase during the forecast period. To expand market reach and to cater to consumer demand, established vendors are adopting R&D activities. Sentry BioPharma Services, Sharp, The WestRock group, and Thermo Fisher Scientific Inc. are a few of the major market participants. Although the increasing approval of novel drugs will offer immense business growth opportunities, the increased chances of drug failure will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market positions, this clinical trial packaging market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. Moreover, this clinical trial packaging market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading clinical trial packaging companies, including:
For more insights on the clinical trial packaging market share of various regions Request for a FREE sample now!
North America was the largest market for clinical trial packaging in 2019, and the region will continue to offer the maximum growth opportunities to market vendors during the forecast period. The increased investments in R&D by large pharmaceutical companies and the presence of a proper regulatory framework for the approval of new drugs are some of the significant factors that will contribute to the clinical trial packaging market growth.
Almost 33% of the market’s growth will originate from North America during the forecast period. The US, Canada, and Mexico are the key markets for clinical trial packaging in North America. Market growth in this region will be faster than the growth of the market in Asia and ROW.
Request for a FREE sample and Get more information on the market contribution of various end-user companies and organizations
The rapid increase in the growth of the pharmaceutical industry, especially in countries such as the US, Japan, Canada, and India, are contributing to the growth of the clinical trial packaging market size. The increase in the industry is significantly attributed to high pharmaceutical R&D spending.
Moreover, market growth by the pharmaceutical companies segment will be faster than the growth of the market by the other organizations segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the clinical trial packaging market share.
The revenue generation for drug manufacturers and developers largely relies on the successful entry and performance of their drug products. As a result, investments in R&D to formulate novel drugs are increasing. Therefore, the approval of drugs has increased dramatically. For instance, according to the US FDA, the CDER approved a total of 59 drugs in 2018, and about 71% of these drugs included new molecular entities. Consequently, registered clinical studies have increased, fueling the demand for pharmacovigilance and drug safety software. This, in turn, has created a demand for clinical trial packaging solutions, driving the clinical trial packaging market growth.
Request for a FREE sample now!
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY END-USER
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.